DH334, a β-carboline anti-cancer drug, Inhibits the CDK activity of budding yeastYan Li, Shuyi Si, Xiuyong Dai et al.|Cancer Biology & Therapy|2007Cited by 77
DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1Jing Zhang, Shuyi Si, Yan Li et al.|Cancer Biology & Therapy|2009Cited by 59
Jadomycin B, an Aurora-B kinase inhibitor discovered through virtual screeningFU Da-hua, Shuyi Si, Yanchang Wang et al.|Molecular Cancer Therapeutics|2008Cited by 55